Ensign (ENSG)


Market Price (7/23/2026): $169.18 | Market Cap: $9.8 BilSector: Health Care | Industry: Health Care Facilities

Ensign (ENSG)


Market Price (7/23/2026): $169.18
Market Cap: $9.8 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 11%

Low stock price volatility
Vol 12M is 29%

Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease. Themes include Geriatric Care.

Weak multi-year price returns
2Y Excs Rtn is -12%

Key risks
ENSG key risks include [1] its heavy reliance on government reimbursement, Show more.

0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 11%
1 Low stock price volatility
Vol 12M is 29%
2 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease. Themes include Geriatric Care.
3 Weak multi-year price returns
2Y Excs Rtn is -12%
4 Key risks
ENSG key risks include [1] its heavy reliance on government reimbursement, Show more.

ENSG in ETFs

Weight = ENSG's share of each fund

VTI0.01%
ITOT0.01%
IWB0.01%
IJH0.28%
VIG0.04%
VB0.11%
IHF1.4%
MDYG0.55%
+21 more covered ETFs

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 7/1/2026

Ensign (ENSG) stock has lost about 15% since 3/31/2026 because of the following key factors:

1. Short-seller reports alleging systemic fraud and inadequate patient care. On June 8, 2026, Hunterbrook Capital published a report alleging that Ensign's business model relies on inadequate patient care, "gaming quality metrics," understaffing, and improper related-party billing, which led to an 8.15% stock drop to $156.42 per share. Subsequently, on June 11, 2026, Muddy Waters Research published a report alleging potential Medicare and Medicaid fraud through a scheme to "rent" administrator licenses from off-site administrators, causing a further 2.98% decline to $147.13 per share. These reports triggered investigations by law firms into potential federal securities law violations.

2. Significant institutional investor divestment. Wasatch Advisors LP, a major institutional investor, reduced its stake in The Ensign Group by 27.5% in fiscal Q1 2026 (ending March 31, 2026), selling 780,571 shares with an estimated value of $157.3 million. This substantial reduction in holdings by a key institutional player signaled a decrease in large-scale investor confidence in the company during the period of stock decline.

Show more
Updated on 7/1/2026

Ensign (ENSG) stock has lost about 15% since 3/31/2026 because of the following key factors:

1. Short-seller reports alleging systemic fraud and inadequate patient care. On June 8, 2026, Hunterbrook Capital published a report alleging that Ensign's business model relies on inadequate patient care, "gaming quality metrics," understaffing, and improper related-party billing, which led to an 8.15% stock drop to $156.42 per share. Subsequently, on June 11, 2026, Muddy Waters Research published a report alleging potential Medicare and Medicaid fraud through a scheme to "rent" administrator licenses from off-site administrators, causing a further 2.98% decline to $147.13 per share. These reports triggered investigations by law firms into potential federal securities law violations.

2. Significant institutional investor divestment. Wasatch Advisors LP, a major institutional investor, reduced its stake in The Ensign Group by 27.5% in fiscal Q1 2026 (ending March 31, 2026), selling 780,571 shares with an estimated value of $157.3 million. This substantial reduction in holdings by a key institutional player signaled a decrease in large-scale investor confidence in the company during the period of stock decline.

3. Revenue miss and analyst downgrades despite an earnings beat. The Ensign Group reported adjusted earnings per share (EPS) of $1.85 for fiscal Q1 2026, exceeding analysts' consensus estimates of $1.78-$1.80. However, the company's consolidated revenue of $1.39 billion slightly missed analyst estimates of $1.40 billion. Following the fiscal Q1 2026 earnings report on April 30, 2026, the stock experienced a slight decline of 0.54%. Additionally, Zacks Research downgraded Ensign Group from a "strong-buy" to a "hold" rating on April 6, 2026, and Weiss Ratings lowered its rating from "buy (b)" to "buy (b-)" on June 16, 2026, contributing to a more cautious investor outlook.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The -16.0% change in ENSG stock from 3/31/2026 to 7/22/2026 was primarily driven by a -20.3% change in the company's P/E Multiple.
(LTM values as of)33120267222026Change
Stock Price ($)201.42169.11-16.0%
Change Contribution By: 
Total Revenues ($ Mil)5,0585,2744.3%
Net Income Margin (%)6.8%6.9%1.3%
P/E Multiple33.726.9-20.3%
Shares Outstanding (Mil)5858-0.3%
Cumulative Contribution-16.0%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2026 to 7/22/2026
ReturnCorrelation
ENSG-16.0% 
Market (SPY)14.9%-15.4%
Sector (XLV)8.7%28.9%

Fundamental Drivers

The -2.9% change in ENSG stock from 12/31/2025 to 7/22/2026 was primarily driven by a -11.7% change in the company's P/E Multiple.
(LTM values as of)123120257222026Change
Stock Price ($)174.07169.11-2.9%
Change Contribution By: 
Total Revenues ($ Mil)4,8295,2749.2%
Net Income Margin (%)6.8%6.9%1.4%
P/E Multiple30.426.9-11.7%
Shares Outstanding (Mil)5758-0.7%
Cumulative Contribution-2.9%

LTM = Last Twelve Months as of date shown

Market Drivers

12/31/2025 to 7/22/2026
ReturnCorrelation
ENSG-2.9% 
Market (SPY)9.9%-7.8%
Sector (XLV)3.4%21.7%

Fundamental Drivers

The 9.8% change in ENSG stock from 6/30/2025 to 7/22/2026 was primarily driven by a 19.2% change in the company's Total Revenues ($ Mil).
(LTM values as of)63020257222026Change
Stock Price ($)154.03169.119.8%
Change Contribution By: 
Total Revenues ($ Mil)4,4235,27419.2%
Net Income Margin (%)7.0%6.9%-1.5%
P/E Multiple28.426.9-5.4%
Shares Outstanding (Mil)5758-1.2%
Cumulative Contribution9.8%

LTM = Last Twelve Months as of date shown

Market Drivers

6/30/2025 to 7/22/2026
ReturnCorrelation
ENSG9.8% 
Market (SPY)22.0%3.5%
Sector (XLV)19.8%26.4%

Fundamental Drivers

The 78.1% change in ENSG stock from 6/30/2023 to 7/22/2026 was primarily driven by a 64.9% change in the company's Total Revenues ($ Mil).
(LTM values as of)63020237222026Change
Stock Price ($)94.95169.1178.1%
Change Contribution By: 
Total Revenues ($ Mil)3,1995,27464.9%
Net Income Margin (%)7.3%6.9%-5.9%
P/E Multiple22.426.919.9%
Shares Outstanding (Mil)5558-4.3%
Cumulative Contribution78.1%

LTM = Last Twelve Months as of date shown

Market Drivers

6/30/2023 to 7/22/2026
ReturnCorrelation
ENSG78.1% 
Market (SPY)74.6%24.2%
Sector (XLV)25.8%36.9%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
ENSG Return15%13%19%19%31%-2%137%
Peers Return4%-47%16%5%68%20%33%
S&P 500 Return27%-19%24%23%16%10%100%

Monthly Win Rates [3]
ENSG Win Rate50%58%67%58%67%29% 
Peers Win Rate50%33%58%45%50%60% 
S&P 500 Win Rate75%42%67%75%67%57% 

Max Drawdowns [4]
ENSG Max Drawdown-28%-25%-14%-15%-19%-32% 
Peers Max Drawdown-42%-67%-39%-46%-32%-39% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: NTRA, GH, OPCH, PGNY, TDOC.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/22/2026 (YTD)

How Low Can It Go

EventENSGS&P 500
2022 Inflation Shock & Fed Tightening
  % Loss-16.8%-24.5%
  % Gain to Breakeven20.2%32.4%
  Time to Breakeven25 days427 days
2020 COVID-19 Crash
  % Loss-52.2%-33.7%
  % Gain to Breakeven109.1%50.9%
  Time to Breakeven143 days140 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-16.3%-3.7%
  % Gain to Breakeven19.5%3.9%
  Time to Breakeven123 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-24.5%-12.2%
  % Gain to Breakeven32.5%13.9%
  Time to Breakeven650 days62 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-29.6%-17.9%
  % Gain to Breakeven42.0%21.8%
  Time to Breakeven199 days123 days
2010 Eurozone Sovereign Debt Crisis / Flash Crash
  % Loss-12.1%-15.4%
  % Gain to Breakeven13.8%18.2%
  Time to Breakeven8 days125 days

Compare to NTRA, GH, OPCH, PGNY, TDOC

In The Past

Ensign's stock fell -5.6% during the 2025 US Tariff Shock. Such a loss loss requires a 5.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventENSGS&P 500
2020 COVID-19 Crash
  % Loss-52.2%-33.7%
  % Gain to Breakeven109.1%50.9%
  Time to Breakeven143 days140 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-24.5%-12.2%
  % Gain to Breakeven32.5%13.9%
  Time to Breakeven650 days62 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-29.6%-17.9%
  % Gain to Breakeven42.0%21.8%
  Time to Breakeven199 days123 days
2008-2009 Global Financial Crisis
  % Loss-49.1%-53.4%
  % Gain to Breakeven96.3%114.4%
  Time to Breakeven154 days1085 days

Compare to NTRA, GH, OPCH, PGNY, TDOC

In The Past

Ensign's stock fell -5.6% during the 2025 US Tariff Shock. Such a loss loss requires a 5.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Ensign (ENSG)

The Ensign Group, Inc. (ENSG) is a healthcare services company specializing in the post-acute care continuum and senior living. The company operates a significant network of healthcare facilities, including skilled nursing centers and senior living communities, primarily across various states in the Western and Midwestern U.S. Ensign's business is structured into two main segments: Skilled Services and Real Estate.

Ensign's core services under its Skilled Services segment include short and long-term skilled nursing care, which addresses the needs of patients with chronic conditions, prolonged illnesses, and the elderly. This encompasses comprehensive rehabilitative therapies such as physical, occupational, and speech therapy, alongside standard services like room and board, special nutritional programs, and social activities. The primary customers are individuals requiring recovery from acute events, long-term care, or supportive senior living environments.

Beyond direct facility-based care, Ensign also offers a range of ancillary services such as mobile diagnostics (including digital x-ray, ultrasound, and electrocardiograms), laboratory services, and patient transportation. These services cater to individuals both within its facilities and in their homes or other long-term care settings. Additionally, the company's Real Estate segment manages and leases properties, which supports its healthcare operations.

AI Analysis | Feedback

Here are 1-2 brief analogies for Ensign (ENSG):

  • It's like a Marriott or Hilton chain, but instead of hotels, they operate skilled nursing homes and senior living facilities.
  • Think of it as an HCA Healthcare (a large hospital operator) that specializes in skilled nursing, rehabilitation, and senior living facilities.

AI Analysis | Feedback

  • Skilled Nursing Care: Provides short and long-term nursing care for patients with chronic conditions, prolonged illness, and the elderly.
  • Rehabilitative Therapies: Offers physical, occupational, and speech therapies and other rehabilitative healthcare services.
  • Senior Living Management: Manages senior living facilities, providing room and board, nutritional programs, and social and recreational services.
  • Mobile Diagnostic & Ancillary Services: Delivers digital x-ray, ultrasound, electrocardiogram, laboratory, and patient transportation services.
  • Real Estate Leasing: Engages in leasing real estate properties, primarily healthcare facilities.

AI Analysis | Feedback

Ensign (symbol: ENSG) sells primarily to individuals. The company serves the following categories of customers:

  1. Elderly individuals and patients with chronic conditions or prolonged illnesses: These customers utilize Ensign's short and long-term nursing care services, skilled nursing, and other related support services provided within its healthcare facilities.
  2. Patients requiring rehabilitative care: This category includes individuals recovering from illness, injury, or surgery who need physical, occupational, or speech therapies to regain function and independence.
  3. Senior living residents: Individuals who reside in Ensign's senior living communities, benefiting from a range of services including room and board, social programs, and assistance with daily living.

AI Analysis | Feedback

null

AI Analysis | Feedback

```html

Barry Port, Chief Executive Officer and Chairman of the Board

Barry Port has served as Chief Executive Officer and a Board Member since May 2019 and was appointed Chairman of the Board in September 2025. Prior to his CEO role, he was Chief Operating Officer of Ensign Services, Inc. from 2012 to 2019. From 2006 to 2011, he served as President of Keystone Care, Inc., overseeing facilities in Texas. His healthcare leadership career began with operational roles directing skilled nursing campuses in Arizona and Texas.

Suzanne D. Snapper, Chief Financial Officer, Executive Vice President and Director

Suzanne D. Snapper has served as Chief Financial Officer since August 2009, having joined Ensign in April 2007. She played a pivotal role as CFO in the successful spin-offs of Care Trust REIT in 2014 and The Pennant Group in 2019, and contributed significantly to the formation of the Standard Bearer REIT in 2022. Before joining Ensign, Ms. Snapper spent ten years as a senior manager at KPMG LLP, where she provided audit services for public companies.

Spencer Burton, President & Chief Operating Officer

Spencer Burton was appointed President and Chief Operations Officer on May 30, 2019. He has nearly 20 years of experience in post-acute care and previously served as President of Pennant Healthcare, Inc., a Northwest-based portfolio company of Ensign Services. Mr. Burton also held leadership roles as Executive Director at affiliated operations in California, Texas, and Washington.

Chad A. Keetch, Chief Investment Officer, Executive Vice President & Secretary

Chad A. Keetch assumed the roles of Chief Investment Officer, Executive Vice President, and Secretary on May 30, 2019. He oversees business development, strategic growth, capital markets activities, new business ventures, and the management of the company's real estate portfolio. Mr. Keetch was instrumental in the spin-off of Care Trust REIT, Inc. in 2014 and The Pennant Group, Inc. in 2019. Prior to joining Ensign, he was a transactional attorney at Stoel Rives LLP (2008-2010) and Kirkland & Ellis LLP (2005-2008), where his practice focused on private equity, mergers and acquisitions, leveraged buyouts, and capital markets transactions.

Beverly B. Wittekind, Vice President and General Counsel

Beverly B. Wittekind serves as Vice President and General Counsel for The Ensign Group, Inc. She also holds the title of Chief Legal Officer for Ensign Services, Inc., where she provides strategic counsel in areas such as risk management, litigation, regulatory compliance, employment law, and dispute resolution. Ms. Wittekind joined Ensign in November 2009.

```

AI Analysis | Feedback

The Ensign Group, Inc. (ENSG) faces several key risks inherent in the post-acute care continuum and skilled nursing facility industry.

  1. Reimbursement Rate Fluctuations and Government Regulation: Changes in government reimbursement policies, particularly for Medicare and Medicaid, represent a primary risk to Ensign Group's revenue streams and financial viability. These changes can include reductions in rates, shifts in state budgets, and the expiration of specific funding programs, such as a California program slated to end after 2026. The company's financial performance is closely linked to these policies, and reductions in reimbursement or delays in payments can materially and adversely affect its operations. Compliance with evolving regulations, including models like the Patient-Driven Payment Model (PDPM), also poses a significant risk.
  2. Labor Shortages and Rising Costs: The healthcare industry, especially the skilled nursing sector, faces persistent labor shortages, wage inflation, and demanding workloads. This workforce crisis, exacerbated by factors like burnout and low wages, contributes to increased operating costs for Ensign Group and can compromise the quality of resident care. The difficulty in recruiting and retaining qualified staff can lead to higher rates of infections, falls, and hospital readmissions, further impacting the business.
  3. Integration of Acquisitions and Competitive Landscape: Ensign Group's growth strategy heavily relies on acquiring and integrating new healthcare facilities. Successfully integrating these newly acquired operations, particularly large portfolios across multiple states, presents a significant challenge. Delays or inefficiencies in this integration process can hinder the realization of expected returns and impact operational performance. Furthermore, the company faces intense competition from other healthcare entities in acquiring, developing, and operating facilities, which can drive up acquisition costs and affect market share.

AI Analysis | Feedback

The accelerating shift towards comprehensive home-based care models, enabled by advancements in telehealth and remote patient monitoring technologies, poses a clear emerging threat. This trend allows for more complex post-acute and rehabilitative care, traditionally provided in skilled nursing facilities or senior living centers, to be delivered effectively and safely in patients' homes. As patient preference and technological capabilities drive this evolution in healthcare delivery, the demand for Ensign's facility-based services could diminish.

AI Analysis | Feedback

Ensign (symbol: ENSG) operates within several significant addressable markets within the U.S. healthcare services sector. These markets include skilled nursing facilities, the broader post-acute care continuum, senior living, and mobile diagnostics services. All market sizes are for the U.S. region.

Skilled Nursing Facilities Market

The U.S. skilled nursing facility market was valued at approximately USD 254.95 billion in 2025 and is projected to reach around USD 388.42 billion by 2035, growing at a compound annual growth rate (CAGR) of 4.3% from 2026 to 2035. Other estimates place the market size at USD 199.72 billion in 2024, with projections to reach USD 290.02 billion by 2033 at a CAGR of 4.39% from 2025 to 2033. Another source indicated a value of USD 202.4 billion in 2025, anticipated to grow to USD 279.9 billion by 2035. A more conservative estimate for the skilled nursing facility segment of the total U.S. post-acute care market in 2025 was approximately USD 130 billion.

Post-Acute Care Market

The U.S. post-acute care (PAC) market, which encompasses skilled nursing, home care, long-term acute care, and inpatient rehabilitation, demonstrates a substantial addressable market. This market was valued at approximately USD 507.12 billion in 2025 and is predicted to increase to around USD 822.98 billion by 2035, exhibiting a CAGR of 4.96% from 2026 to 2035. Other estimates for the U.S. post-acute care market size in 2025 include USD 490.6 billion, with a projection to reach USD 898.5 billion by 2035 at a CAGR of 6.4% from 2026 to 2035. Another report valued the market at USD 461.38 billion in 2025, expecting it to reach approximately USD 766.71 billion by 2035, growing at a CAGR of 5.21% from 2026 to 2035.

Senior Living Market

The U.S. senior living market size was valued at USD 943.90 billion in 2025 and is expected to reach USD 1.33 trillion by 2033, growing at a CAGR of 4.47% from 2026 to 2033. Another report estimated the market size at USD 923.75 billion in 2023, with a projection to reach approximately USD 1,391.23 billion by 2033, demonstrating a CAGR of 4.18% during the forecast period from 2024 to 2033.

Mobile Diagnostics Services Market

The U.S. mobile imaging services market, which includes digital x-ray, ultrasound, and EKG services as provided by Ensign, was valued at USD 5.3 billion in 2022. More specifically for mobile MRI services, the U.S. market size was estimated at USD 3.99 billion in 2025 and is projected to reach around USD 5.67 billion by 2035, with a CAGR of 3.58% from 2026 to 2035. Another report indicated the U.S. mobile MRI services market size was estimated at USD 3.67 billion in 2024.

AI Analysis | Feedback

The Ensign Group, Inc. (ENSG) is expected to drive future revenue growth over the next 2-3 years through several key strategies:
  1. Strategic Acquisitions and Portfolio Expansion: Ensign Group consistently expands its portfolio by acquiring skilled nursing and post-acute care facilities. The company often targets facilities with turnaround potential or long-term value, integrating them into its decentralized operating model. For instance, the company acquired 45 new operations in 2025 and added 52 new operations since the beginning of 2024, expanding its footprint across various states. This acquisition-driven growth is a core part of its strategy, with management's 2026 guidance assuming continued acquisition activity.
  2. Organic Growth through Enhanced Occupancy and Patient Mix: The company focuses on improving occupancy rates and attracting a higher-acuity patient mix (Medicare and managed care). Ensign has demonstrated strong organic growth, with same-facilities occupancy improving and transitioning-facilities occupancy increasing year-over-year. This improvement in occupancy, coupled with an increased number of skilled patient days and higher Medicare and managed care revenues, significantly contributes to revenue growth. Management believes significant organic growth potential remains, as many facilities have yet to reach peak occupancy levels.
  3. Expansion and Optimization of Service Offerings: Ensign Group's revenue expansion is driven by increasing service offerings in skilled nursing, rehabilitation, and senior living. The growing elderly population in the U.S. continues to fuel demand for these services, supporting Ensign's long-term outlook. The company's ability to offer advanced healthcare services, particularly rehabilitation, is anticipated to contribute significantly to the revenue growth of its Skilled Services segment.
  4. Strategic Real Estate Investments via Standard Bearer Healthcare REIT: Through its captive real estate investment trust (REIT), Standard Bearer Healthcare REIT, Inc., Ensign acquires and owns underlying real estate assets. This strategy provides both operational and real estate investment returns, with Standard Bearer capturing real estate value and contributing to financial stability through consistent rental income. The Standard Bearer segment saw a 33.9% increase in funds from operations in Q4 2025.
  5. Favorable Pricing and Reimbursement Trends: Ensign has benefited from price increases, as evidenced by its revenue growth outpacing the growth in units sold over the past two years. The company has also shown substantial year-over-year growth in same-store Medicare revenue and managed care revenue, indicating improved reimbursement rates for its skilled services. The ability of local partners to build clinical capabilities helps attract a higher-quality patient population with better reimbursement prospects.

AI Analysis | Feedback

Share Repurchases

  • The Ensign Group repurchased shares worth $20 million in 2025.
  • As of September 30, 2024, the company did not make any purchases under its stock repurchase program.

Share Issuance

  • Ensign's shares outstanding for the quarter ending December 31, 2025, were 0.059 billion, representing a 1.09% increase year-over-year.
  • Shares outstanding increased by 1.09% in 2025 from 2024, and by 1.6% in 2024 from 2023.

Outbound Investments

  • In 2025, The Ensign Group completed 51 acquisitions, including 12 real estate assets.
  • Effective December 1, 2025, the company acquired the operations of four skilled nursing facilities in Colorado, Kansas, and Arizona.
  • The Ensign Group acquired operations of Agave Grove Post Acute and four other skilled nursing facilities, as well as real estate in Texas and Wisconsin, effective February 1, 2026.

Capital Expenditures

  • Accrued capital expenditures were $7.3 million for the nine months ended September 30, 2024, and $4.1 million for the same period in 2023.
  • Capital investments are primarily focused on upgrading facilities, adding beds, and developing new healthcare infrastructure.
  • A strategic focus for capital expenditures includes acquiring newer assets and improving existing physical plants to enhance care quality and census rates.

Better Bets vs. Ensign (ENSG)

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

ENSGNTRAGHOPCHPGNYTDOCMedian
NameEnsign Natera Guardant.Option C.Progyny Teladoc . 
Mkt Price169.11264.22150.7521.1531.358.9291.05
Mkt Cap9.837.419.83.32.50.16.5
Rev LTM5,2742,5011,0805,6671,2932,5142,508
Op Inc LTM449-324-44833196-157-30
FCF LTM21672-237213184127156
FCF 3Y Avg200-14-281243190169180
CFO LTM592211-188254206288232
CFO 3Y Avg44775-247284201311242

Growth & Margins

ENSGNTRAGHOPCHPGNYTDOCMedian
NameEnsign Natera Guardant.Option C.Progyny Teladoc . 
Rev Chg LTM19.2%36.6%39.6%9.3%6.6%-1.5%14.3%
Rev Chg 3Y Avg18.2%42.5%31.0%12.0%14.3%0.7%16.2%
Rev Chg Q18.4%38.8%48.3%1.3%1.4%-2.5%9.9%
QoQ Delta Rev Chg LTM4.3%8.4%10.0%0.3%0.3%-0.6%2.3%
Op Inc Chg LTM18.9%-42.7%1.6%-0.2%32.0%15.8%8.7%
Op Inc Chg 3Y Avg16.5%9.1%6.8%9.7%38.1%11.0%10.4%
Op Mgn LTM8.5%-13.0%-41.4%5.8%7.5%-6.3%-0.2%
Op Mgn 3Y Avg8.0%-19.0%-62.7%6.5%6.5%-7.4%-0.5%
QoQ Delta Op Mgn LTM0.1%0.5%3.1%-0.1%0.8%0.2%0.3%
CFO/Rev LTM11.2%8.4%-17.4%4.5%16.0%11.5%9.8%
CFO/Rev 3Y Avg9.8%1.8%-33.0%5.6%16.7%12.1%7.7%
FCF/Rev LTM4.1%2.9%-22.0%3.8%14.3%5.0%3.9%
FCF/Rev 3Y Avg4.5%-2.8%-37.1%4.8%15.9%6.6%4.6%

Valuation

ENSGNTRAGHOPCHPGNYTDOCMedian
NameEnsign Natera Guardant.Option C.Progyny Teladoc . 
Mkt Cap9.837.419.83.32.50.16.5
P/S1.914.918.30.62.00.01.9
P/Op Inc21.8-115.3-44.210.026.3-0.34.8
P/EBIT20.1-132.5-46.09.926.3-0.34.8
P/E26.9-165.2-45.716.137.5-0.37.9
P/CFO16.5177.2-105.413.112.30.212.7
Total Yield3.9%-0.6%-2.2%6.2%2.7%-321.3%1.0%
Dividend Yield0.1%0.0%0.0%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg2.5%-0.3%-4.8%5.5%8.4%324.1%4.0%
D/E0.20.00.10.40.019.50.2
Net D/E0.2-0.00.00.3-0.15.40.1

Returns

ENSGNTRAGHOPCHPGNYTDOCMedian
NameEnsign Natera Guardant.Option C.Progyny Teladoc . 
1M Rtn7.9%15.5%17.0%-0.7%19.3%17.7%16.2%
3M Rtn-9.2%27.2%68.3%-25.5%74.3%50.7%38.9%
6M Rtn-4.9%8.8%30.2%-41.7%23.2%44.8%16.0%
12M Rtn24.2%88.8%225.9%-29.0%36.4%5.9%30.3%
3Y Rtn82.1%435.8%300.3%-36.0%-21.5%-62.0%30.3%
1M Excs Rtn7.6%15.1%16.7%-1.1%18.9%17.3%15.9%
3M Excs Rtn-17.9%22.5%60.7%-30.8%67.8%42.5%32.5%
6M Excs Rtn-14.9%2.2%20.9%-51.2%13.2%36.6%7.7%
12M Excs Rtn4.4%69.0%211.4%-46.4%17.7%-11.8%11.1%
3Y Excs Rtn23.2%370.7%232.3%-102.1%-87.6%-130.1%-32.2%

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Skilled Services4,8384,0773,5792,9062,523
All other revenue233193156123103
Standard Bearer12795827358
Elimination of intercompany revenue-140-104-88-76-57
Total5,0584,2603,7293,0252,627


Operating Income by Segment
$ Mil20192018201720162015
Skilled Services244191140118 
All other revenue-114-104-95-55-69
Assisted and Independent Living Services 151712 
Home Health and Hospice Services 26201714
TSA Services    148
Total129128819293


Price Behavior

Price Behavior
Market Price$169.11 
Market Cap ($ Bil)9.8 
First Trading Date11/09/2007 
Distance from 52W High-21.6% 
   50 Days200 Days
DMA Price$166.17$182.65
DMA Trendindeterminatedown
Distance from DMA1.8%-7.4%
 3M1YR
Volatility32.0%29.0%
Downside Capture-102.32-22.96
Upside Capture-121.597.46
Correlation (SPY)-27.6%2.6%
ENSG Betas & Captures as of 6/30/2026

 1M2M3M6M1Y3Y
Beta-0.79-0.61-0.18-0.140.110.42
Up Beta-0.020.410.600.340.550.47
Down Beta0.01-0.11-0.38-0.23-0.190.30
Up Capture-149%-123%-63%-26%7%20%
Bmk +ve Days11244067140429
Stock +ve Days11172656121386
Down Capture-107%-82%-26%-23%8%64%
Bmk -ve Days10172358112321
Stock -ve Days10243769131364

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ENSG
ENSG23.4%28.9%0.72-
Sector ETF (XLV)23.3%15.8%1.1326.0%
Equity (SPY)20.0%12.6%1.162.5%
Gold (GLD)21.2%28.1%0.67-2.7%
Commodities (DBC)33.0%19.1%1.36-20.1%
Real Estate (VNQ)13.9%14.0%0.7027.1%
Bitcoin (BTCUSD)-43.6%42.9%-1.21-16.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ENSG
ENSG14.4%26.8%0.50-
Sector ETF (XLV)6.0%15.0%0.2239.7%
Equity (SPY)12.8%17.1%0.5834.6%
Gold (GLD)17.3%18.4%0.764.7%
Commodities (DBC)9.3%19.5%0.373.0%
Real Estate (VNQ)2.7%18.9%0.0442.4%
Bitcoin (BTCUSD)15.2%53.5%0.467.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ENSG
ENSG24.1%36.1%0.70-
Sector ETF (XLV)9.8%16.6%0.4846.1%
Equity (SPY)15.1%17.9%0.7246.5%
Gold (GLD)11.5%16.1%0.583.7%
Commodities (DBC)7.1%17.9%0.3114.9%
Real Estate (VNQ)5.0%20.7%0.2045.7%
Bitcoin (BTCUSD)58.5%66.2%0.9913.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date6302026
Short Interest: Shares Quantity2.1 Mil
Short Interest: % Change Since 6152026-23.0%
Average Daily Volume1.7 Mil
Days-to-Cover Short Interest1.2 days
Basic Shares Quantity57.8 Mil
Short % of Basic Shares3.6%

Returns Analyses

Earnings Returns History

Updated 6/10/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
4/30/2026-1.6%-6.6%-11.6%
2/4/202613.8%22.4%19.7%
11/3/20250.1%-1.3%-3.2%
7/24/20258.9%8.9%25.2%
4/29/20250.7%4.2%14.4%
2/5/2025-8.7%-15.3%-12.4%
10/24/20242.7%4.1%-1.7%
7/25/20244.9%2.5%8.7%
...
SUMMARY STATS   
# Positive141415
# Negative10109
Median Positive5.1%6.4%12.3%
Median Negative-2.5%-4.3%-7.7%
Max Positive15.0%22.4%26.4%
Max Negative-8.7%-15.3%-12.4%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
4/30/2026-1.6%-6.6%-11.6%
2/4/202613.8%22.4%19.7%
11/3/20250.1%-1.3%-3.2%
7/24/20258.9%8.9%25.2%
4/29/20250.7%4.2%14.4%
2/5/2025-8.7%-15.3%-12.4%
10/24/20242.7%4.1%-1.7%
7/25/20244.9%2.5%8.7%
5/1/2024-2.4%-2.8%1.5%
2/1/20244.7%2.3%9.2%
10/25/20230.3%1.5%15.3%
7/27/20232.9%9.0%8.6%
4/26/2023-3.6%-6.0%-10.8%
2/2/2023-1.7%-5.3%-3.9%
10/26/2022-4.0%0.6%4.5%
8/1/20226.5%4.9%3.4%
4/28/2022-2.0%-5.1%0.5%
2/9/20225.3%7.9%13.1%
10/27/202110.0%13.1%12.3%
7/28/2021-3.6%-3.5%-7.7%
4/29/2021-1.0%-1.6%-4.0%
2/3/2021-2.7%-2.9%-9.1%
10/28/20205.5%10.6%26.4%
8/5/202015.0%15.7%17.7%
SUMMARY STATS   
# Positive141415
# Negative10109
Median Positive5.1%6.4%12.3%
Median Negative-2.5%-4.3%-7.7%
Max Positive15.0%22.4%26.4%
Max Negative-8.7%-15.3%-12.4%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202604/30/202610-Q
12/31/202502/04/202610-K
09/30/202511/03/202510-Q
06/30/202507/24/202510-Q
03/31/202504/29/202510-Q
12/31/202402/05/202510-K
09/30/202410/24/202410-Q
06/30/202407/25/202410-Q
03/31/202405/01/202410-Q
12/31/202302/01/202410-K
09/30/202310/25/202310-Q
06/30/202307/27/202310-Q
03/31/202304/26/202310-Q
12/31/202202/02/202310-K
09/30/202210/26/202210-Q
06/30/202208/01/202210-Q
Collapse to Preview
Report DateFiling DateFiling
03/31/202604/30/202610-Q
12/31/202502/04/202610-K
09/30/202511/03/202510-Q
06/30/202507/24/202510-Q
03/31/202504/29/202510-Q
12/31/202402/05/202510-K
09/30/202410/24/202410-Q
06/30/202407/25/202410-Q
03/31/202405/01/202410-Q
12/31/202302/01/202410-K
09/30/202310/25/202310-Q
06/30/202307/27/202310-Q
03/31/202304/26/202310-Q
12/31/202202/02/202310-K
09/30/202210/26/202210-Q
06/30/202208/01/202210-Q
03/31/202204/28/202210-Q
12/31/202102/09/202210-K
09/30/202110/27/202110-Q
06/30/202107/28/202110-Q
03/31/202104/29/202110-Q
12/31/202002/03/202110-K
09/30/202010/28/202010-Q
06/30/202008/05/202010-Q
03/31/202005/11/202010-Q
12/31/201902/05/202010-K
09/30/201910/30/201910-Q
06/30/201908/01/201910-Q

Recent Forward Guidance

Updated 7/12/2026

Latest: Q1 2026 Earnings Reported 4/30/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Earnings Per Share7.487.557.62  RaisedGuidance: 7.51 for 2026
2026 Revenue5.81 Bil5.83 Bil5.86 Bil  RaisedGuidance: 5.80 Bil for 2026

Prior: Q4 2025 Earnings Reported 2/4/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Revenue5.77 Bil5.80 Bil5.84 Bil14.7% Higher NewGuidance: 5.06 Bil for 2025
2026 EPS7.417.517.6115.4% Higher NewGuidance: 6.51 for 2025

Q3 2025 Earnings Reported 11/3/2025

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2025 Annual Earnings Per Share6.486.516.541.7% RaisedGuidance: 6.4 for 2025
2025 Annual Revenue5.05 Bil5.06 Bil5.07 Bil1.1% RaisedGuidance: 5.00 Bil for 2025

Insider Activity

Updated 7/22/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Agwunobi, John O DirectSell7222026171.0639267,0561,625,609Form
2Parkinson, Mark Vincent DirectSell7172026168.1210016,812655,668Form
3Smith, Barry M DirectSell6042026164.28700114,9963,507,707Form
4Smith, Barry M DirectSell5062026182.21700127,5474,018,095Form
5Agwunobi, John O DirectSell4222026199.9739278,3881,858,751Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Agwunobi, John O DirectSell7222026171.0639267,0561,625,609Form
2Parkinson, Mark Vincent DirectSell7172026168.1210016,812655,668Form
3Smith, Barry M DirectSell6042026164.28700114,9963,507,707Form
4Smith, Barry M DirectSell5062026182.21700127,5474,018,095Form
5Agwunobi, John O DirectSell4222026199.9739278,3881,858,751Form
6Parkinson, Mark Vincent DirectSell4172026196.6010019,660668,440Form
7Smith, Barry M DirectSell4062026196.65700137,6554,356,191Form
8Smith, Barry M DirectSell3022026213.02700149,1144,867,933Form
9Shaw, Daren DirectSell2192026213.431,000213,4305,063,840Form
10Parkinson, Mark Vincent DirectSell2092026198.0010019,800574,200Form
11Blouin, Ann Scott DirectSell2092026198.0037574,2504,524,696Form
12Snapper, Suzanne DCFODirectSell2092026196.114,573896,82353,516,991Form
13Snapper, Suzanne DCFODirectSell2092026194.488,2581,606,05653,962,144Form
14Smith, Barry M DirectSell2042026171.54700120,0784,040,110Form
15Agwunobi, John O DirectSell1222026178.3114626,0331,620,330Form
16Agwunobi, John O DirectSell1222026179.8224644,2361,660,305Form
17Smith, Barry M DirectSell1062026173.59700121,5134,105,751Form
18Wittekind, Beverly BVP and Chief Legal OfficerDirectSell12232025180.002,000360,0005,900,220Form
19Wittekind, Beverly BVP and Chief Legal OfficerDirectSell12162025175.488,4001,474,0005,751,933Form
20Smith, Barry M DirectSell12032025184.27700128,9894,487,343Form
21Burton, SpencerPresident and COODirectSell11242025180.003,690664,2009,209,700Form
22Burton, SpencerPresident and COODirectSell11192025180.002,209397,6209,209,700Form
23Shaw, Daren DirectSell11192025178.571,000178,5704,308,180Form
24Burton, SpencerPresident and COODirectSell11192025177.305,8991,045,8939,071,554Form
25Port, BarryChief Executive OfficerDirectSell11132025180.7128,3155,116,70010,206,474Form
26Uychiat, Pison Marivic DirectSell11072025182.087313,2922,638,339Form
27Agwunobi, John O DirectSell11072025188.8724646,4621,677,005Form
28Smith, Barry M DirectSell11052025180.64700126,4484,525,393Form
29Smith, Barry M DirectSell10032025172.00700120,4004,326,144Form
30Smith, Barry M DirectSell9042025172.06700120,4424,654,567Form
31Shaw, Daren DirectSell8192025166.171,000166,1704,075,485Form
32Port, BarryChief Executive OfficerDirectSell8122025160.002,399383,8409,124,800Form
33Smith, Barry M DirectSell8042025150.00700105,0004,162,800Form
34Blouin, Ann Scott DirectSell8042025149.2342563,4233,287,089Form
35Snapper, Suzanne DCFODirectSell7092025148.218,3791,241,82139,970,061Form
36Smith, Barry M DirectSell7032025153.48700107,4364,274,725Form

Investor Activity (13F)

Updated Jul 23, 2026
13F holdings as of Mar 31, 2026 (Q1 2026)

Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.

Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Owls Nest Partners IA, LLC$45.4 Mil15.9%13TRIM -25.0%13F
Crow's Nest Holdings LP$62.0 Mil14.5%11TRIM -20.1%13F
Turtle Creek Asset Management Inc.$51.8 Mil1.9%39TRIM -23.7%13F
Hound Partners, LLC$11.2 Mil1.4%34TRIM -14.7%13F
Active Manager
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Owls Nest Partners IA, LLC$45.4 Mil15.9%13TRIM -25.0%13F
Turtle Creek Asset Management Inc.$51.8 Mil1.9%39TRIM -23.7%13F
Crow's Nest Holdings LP$62.0 Mil14.5%11TRIM -20.1%13F
Hound Partners, LLC$11.2 Mil1.4%34TRIM -14.7%13F
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Crow's Nest Holdings LP$62.0 Mil14.5%11TRIM -20.1%13F
Turtle Creek Asset Management Inc.$51.8 Mil1.9%39TRIM -23.7%13F
Owls Nest Partners IA, LLC$45.4 Mil15.9%13TRIM -25.0%13F
Hound Partners, LLC$11.2 Mil1.4%34TRIM -14.7%13F
Core Cache Last Updated: 7/22/2026